logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Mihai V Podgoreanu

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignee: Duke University. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihai V Podgoreanu. Retrieved from https://idiyas.com/inventor/mihai-v-podgoreanu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 25.0

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Raleigh, NC (US) (2009)
  • Durham, NC (US) (2008 - 2017)
  • Chapel Hill, NC (US) (2015 - 2019)

Company Filing History:

goldMedal8 out of 2,085 
 
Duke University
 patents

Years Active: 2008-2019

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10378056 - Compositions and methods for identifying altered effectiveness of beta blocker therapy (2019-08-13),
2. 10172915 - Methods and compositions for activation of sirtuins with Annexin A1 peptides (2019-01-08),
3. 9556486 - Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke (2017-01-31),
4. 9173918 - Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide (2015-11-03),
5. 8940697 - Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide (2015-01-27),
6. 8187807 - Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke (2012-05-29),
7. 7592141 - Methods of identifying individuals at reduced risk of sepsis (2009-09-22),
8. 7439019 - Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction (2008-10-21),

Title: Innovator Mihai V Podgoreanu: Advancements in Therapeutic Methods

Introduction

Mihai V Podgoreanu, an accomplished inventor based in Chapel Hill, NC, has made significant contributions to the field of medicine through his innovative patents. With a total of eight patents to his name, he is recognized for his work in enhancing therapeutic methods, particularly in the area of beta blocker therapy.

Latest Patents

Two of his latest patents showcase his focus on personalized medicine and treatment specificity. The first patent, titled "Compositions and methods for identifying altered effectiveness of beta blocker therapy," introduces a method that identifies individuals at an elevated risk of experiencing altered therapeutic responses due to specific genetic variations. This invention aims to refine the efficacy of beta blocker treatments by tailoring them to individual genetic profiles.

The second patent, "Methods and compositions for activation of sirtuins with Annexin A1 peptides," presents a novel approach for treating and alleviating sirtuin-associated disorders. By administering effective amounts of Annexin A1 peptides, this method provides a promising avenue for addressing specific health conditions that are linked to sirtuin activity.

Career Highlights

Mihai V Podgoreanu is currently affiliated with Duke University, where his research and innovations continue to flourish. His work has not only advanced understanding in pharmacogenomics but also underscored the importance of personalizing medical treatments.

Collaborations

Throughout his career, Podgoreanu has collaborated with esteemed colleagues, including Debra A Schwinn and Mark F Newman. These collaborations have been instrumental in driving forward groundbreaking research and developing effective therapeutic strategies.

Conclusion

Mihai V Podgoreanu stands out as a key figure in the field of medical innovation. His eight patents reflect his dedication to improving patient care through personalized medicine. As he continues to work at Duke University, the future holds great promise for further advancements in healthcare stemming from his inventive spirit.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…